Table 1.

Infection status and clinicopathological findings in rhesus macaques

AnimalInfection duration (wk)Infection stagePlasma viral copies/mLSIV ISH*IFN-γ ISH*Clinicopathological findings
SplAxLNIngLNSplAxLN
M5299 Acute 10 000 000 45.8 50.0 61.0 9.9 24.8 Mild hypercellularity in LN, gastritis 
M5499 Acute 6 500 0001-153 65.9 65.4 44.0 6.9 23.4 Reduced % CD4+
T lymphocytes 
M5599 Acute 54 000 1.5 2.3 1.1 2.9 7.7 None 
M5699 Acute 63 000 000 28.1 55.2 59.7 25.9 81.8 None 
M0999 Acute 29 000 000 17.5 8.0 7.3 9.1 2.9 None 
M5899 Acute 14 000 0001-153 29.6 5.8 6.2 12.8 5.5 Reduced % CD4+ T lymphocytes, mild LH, gastritis 
M5999 Acute 7 000 000 24.1 32.1 44.0 7.7 49.7 Reduced % CD4+ T lymphocytes 
M6299 Acute 34 000 000 22.6 53.3 77.2 17.2 34.0 Reduced % CD4+ T lymphocytes 
M1799 21 AIDS 780 000 13.3 7.3 14.6 11.0 9.9 Weight loss, CD4+ T-lymphocyte loss, Pc, LH 
M5199 24 AIDS 540 000 13.3 28.1 38.4 4.0 16.1 Weight loss, CD4+ T-lymphocyte loss, Pc, LH 
M6199 32 AIDS 940 000 6.9 15.3 12.8 17.2 8.0 Weight loss, CD4+ T-lymphocyte loss, mild encephalitis, LH 
M5799 55 AIDS 28 000 000 10.2 13.2 26.3 6.6 5.5 Weight loss, CD4+ T-lymphocyte loss, B-lymphocytic lymphoma, LH 
M95971-154 384 Chronic/LTNP < 50 23.4 2.2 Mild LH 
M5600 NA Uninfected ND 1.5 0.7 None 
M6600 NA Uninfected ND 1.8 0.4 None 
AnimalInfection duration (wk)Infection stagePlasma viral copies/mLSIV ISH*IFN-γ ISH*Clinicopathological findings
SplAxLNIngLNSplAxLN
M5299 Acute 10 000 000 45.8 50.0 61.0 9.9 24.8 Mild hypercellularity in LN, gastritis 
M5499 Acute 6 500 0001-153 65.9 65.4 44.0 6.9 23.4 Reduced % CD4+
T lymphocytes 
M5599 Acute 54 000 1.5 2.3 1.1 2.9 7.7 None 
M5699 Acute 63 000 000 28.1 55.2 59.7 25.9 81.8 None 
M0999 Acute 29 000 000 17.5 8.0 7.3 9.1 2.9 None 
M5899 Acute 14 000 0001-153 29.6 5.8 6.2 12.8 5.5 Reduced % CD4+ T lymphocytes, mild LH, gastritis 
M5999 Acute 7 000 000 24.1 32.1 44.0 7.7 49.7 Reduced % CD4+ T lymphocytes 
M6299 Acute 34 000 000 22.6 53.3 77.2 17.2 34.0 Reduced % CD4+ T lymphocytes 
M1799 21 AIDS 780 000 13.3 7.3 14.6 11.0 9.9 Weight loss, CD4+ T-lymphocyte loss, Pc, LH 
M5199 24 AIDS 540 000 13.3 28.1 38.4 4.0 16.1 Weight loss, CD4+ T-lymphocyte loss, Pc, LH 
M6199 32 AIDS 940 000 6.9 15.3 12.8 17.2 8.0 Weight loss, CD4+ T-lymphocyte loss, mild encephalitis, LH 
M5799 55 AIDS 28 000 000 10.2 13.2 26.3 6.6 5.5 Weight loss, CD4+ T-lymphocyte loss, B-lymphocytic lymphoma, LH 
M95971-154 384 Chronic/LTNP < 50 23.4 2.2 Mild LH 
M5600 NA Uninfected ND 1.5 0.7 None 
M6600 NA Uninfected ND 1.8 0.4 None 

SIV indicates simian immunodeficiency virus; ISH, in situ hybridization; IFN-γ, interferon γ; Spl, spleen; AxLN, axillary lymph nodes; IngLN, inguinal lymph nodes; LN, lymph nodes; LH, lymphoid hyperplasia; AIDS, acquired immunodeficiency syndrome; Pc,Pneumocystis carinii infection; LTNP, long-term nonprogressor; NA, not applicable; and ND, not done.

*

Numbers of RNA-positive cells/mm2 determined by ISH.

All macaques were inoculated intravenously with a characterized stock of the pathogenic isolate SIV/ΔB670.6 

Real-time reverse transcriptase–polymerase chain reaction was used to determine plasma viral loads.

F1-153

Values for samples obtained 2 weeks after infection were not available; values are for the week 1 time point.

F1-154

This animal was an LTNP that was described previously.7 

Close Modal

or Create an Account

Close Modal
Close Modal